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Abstract
Background: Abdominal migraine is a commonly described migraine variant in children and young adults, but
associations with Alice in Wonderland syndrome and lilliputian hallucinations are exceptional.
Case presentation: A 20 years-old male experienced frequent and prolonged attacks of abdominal colic
associated with autonomic manifestations started at the age of ten. At the age of 17, he additionally described
prolonged attacks (≥ 7 days) of distortions of shape, size or position of objects or subjects. He said “Quite
suddenly, objects appear small and distant (teliopsia) or large and close (peliopsia). I feel as I am getting shorter
and smaller “shrinking” and also the size of persons are not longer than my index finger (a lilliputian proportion).
Sometimes I see the blind in the window or the television getting up and down, or my leg or arm is swinging. I
may hear the voices of people quite loud and close or faint and far. Occasionally, I experience attacks of
migrainous headache associated with eye redness, flashes of lights and a feeling of giddiness. I am always
conscious to the intangible changes in myself and my environment”. There is a strong family history of common
migraine. Clinical examination, brain-MRI and EEG were normal. Transcranial magnetic stimulation and evoked
potentials revealed enhanced cortical excitability in multiple brain regions. Treatment with valproate resulted in
marked improvement of all clinical and neurophysiological abnormalities.
Conclusions: The association between the two migraine variants (abdominal migraine and Alice in Wonderland
Syndrome) might have clinical, pathophysiological and management implications. I think this is the first description
in the literature.
Background
Migraine variants (MVs) or migraine equivalents exhibit
themselves in forms other than head pain. MVs are less
recognized and poorly understood entities of migraine.
They are encountered in 3-5% of patients with migraine
and usually affect children and young adults [1].
Abdominal migraine is a common MV. Typically,
abdominal migraine affects ~20% of children with
migraine. It occurs at the age of 5-9 years [2]. Also MVs
may occur in the form of paroxysmal prolonged visual
aura, paroxysmal vertigo, and rarely auditory, sensory or
motor hallucinations. MVs with complex presentation
are very rare; remain undefined by the International
Classification of Headache Disorders (ICHD-II 2004)
and seen in the literature as sporadic case reports [3-8].
Alice in Wonderland Syndrome (AWLS) is a rare MV.
Collectively manifestations of AIWS include: micropsia
(objects appear too small); macropsia (objects appear
too big); teleopsia (objects seem too far away); lillipu-
tianism (people appear too small); palinopsia (the persis-
tence or recurrence of visual images after removal of the
exciting stimulus); cerebralp o l y o p i a( t h e perception of
multiple images); metamorphopsia (distortion of the
shapes of objects); zoopsia (visual hallucinations con-
taining complex objects, such as people and animals);
achromatopsia (no perception of color); prosopagnosia
(inability to recognize faces); visual agnosia (inability to
recognize objects) and akinetopsia (loss of ability to per-
ceive visual motion) [9]. Manifestations of AIWS were
firstly described by Lippman [10]. In 1952, Lippman
described seven migraineurs who had unusual
* Correspondence: hamed_sherifa@yahoo.com
1Department of Neurology and Psychiatry, Assiut University Hospital, Assiut,
Egypt
Hamed BMC Neurology 2010, 10:2
http://www.biomedcentral.com/1471-2377/10/2
© 2010 Hamed; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.distortions of body image. In 1955, Todd gave the syn-
drome its name [11]. Todd identified variety of self-
experienced paroxysmal body schema disturbances as
symptoms of AWLS (as depersonalization, derealization,
visual illusions and disorders of the time perception).
Historically, AWLS derived its name after Lewis Carroll
book “Alice’s Adventures in Wonderland”.I nt h eb e g i n -
ning of Carroll’s book, the title character “Alice” found
her-self growing and shrinking because of eating or
drinking some strange creations. In fact, Lewis Carroll
was said to have gotten migraine as early as 1856 and
this helped him to inspire the fifth chapter of his book
[12,13].
MVs should be differentiated from organic, psychiatric
or central nervous system diseases with similar clinical
presentation. In MVs, various molecular and cellular
mechanisms may increase the susceptibility of cortical
spreading depression (CSD), a main pathophysiologic
mechanism associated with migraine. CSD is a slow cor-
tical depolarization that progress from one brain area to
its contiguous resulting in transient oligemia or ische-
mia, followed by hyperemia in different cortical areas
and the associated multiple neurological phenomena
[14].
Case presentation
Twenty years-old Egyptian male was referred by an
internist for neurological assessment. At presentation,
the patient was curled up in a fetal position and only
bent his head in response to questions, because he was
experiencing intense and prolonged attacks of colic cen-
tered in his mid-abdomen. The colic attacks started at
t h ea g eo ft e n .E a r l ya tt h eo n s e t ,t h ea t t a c k sw e r e
shorter in duration (few hours to 24 hours) and
recurred every 3-5 months. They progressed in duration
and frequency as in the last year before presentation,
they were recurring weekly and each continued up to 72
hours. The attacks were accompanied by nausea,
abdominal flushing, pallor, tachycardia and diarrhea (but
never vomiting). The patient said that abdominal dis-
comfort leaves as suddenly as it comes, offering no clue
to when it will return. But he recognized eating fish or
its products as strong triggers for the colic. The pain
was severe enough to make him refuse to eat or drink
for prolonged periods. This resulted in unintentional
weight loss (the patient was 45 kilos at presentation),
slowed growth and limited life activities and school
attendance. The referral internist excluded the presence
of organic disorder as a cause of patient’s manifestations
based on medical evaluation and unremarkable labora-
tory tests (blood, urine and stool analyses), abdominal
imaging and endoscopic examinations. Long-term anti-
epileptic treatment with carbamazepine was prescribed
to the patient by a pediatrician based on the presence of
epileptic activity in the electroencephalogram (EEG).
Long-term treatment with colchicine was prescribed by
another internist because of the misdiagnosis as Medi-
terranean Fever although the patient never experienced
attacks of fever or serositis.
At the clinic and in front of the consulting neurolo-
gist, the patient developed the attacks of abdominal
colic. The patient was not only feeling miserable, but
looked it too. He was pale and curled up with sucked
abdomen. Neither loss of consciousness nor postictal
confusion was witnessed. Immediate EEG was normal.
At the age of 17, the patient developed abnormal
visual phenomena in between the attacks of abdominal
colic which lasted longer than a week. The patient said:
“Quite suddenly everything seems strange, unusually I
see objects small and distant (teliopsia) or large and
close (peliopsia). I feel that I am getting shorter and
smaller “shrinking” and also the size of persons are not
longer than my index finger (a Lilliputian proportion). I
see the same by either eye separately. I see the blind in
the window or the television gets up and down, or my
leg or arm is swinging. I hear people’sv o i c e sl o u da n d
close or faint and far. I am always conscious of the
intangible changes in myself and my environment. I am
least likely to be distressed by those hallucinations as I
find them non-threatening and I also get familiar with
them. Occasionally at the end of the third day of an
abdominal attack, I develop attacks of throbbing hemi-
cranial headache associated with eye redness, flashes of
lights and a feeling of giddiness which lasts no longer
than 15 minutes”. There is a strong family history (his
father, 2 sisters and one brother) of recurrent hemicra-
nial headaches associated with eye redness, anxiety, nau-
sea and vomiting, that lasted for a period of hours to 3
days and sometimes improved with NSAIDs. The mani-
festations are suggestive of a common migraine disorder.
There were no previous histories of trauma, drug inges-
tion, epilepsy, other central nervous system or psychia-
tric disorders.
Diagnostic testing was done to distinguish primary
from secondary causes that share similar features. Diag-
nostic workup did not reveal another cause. MRI-brain
(regular and diffusion-weighted) was normal. Interictal
video EEG using basal temporal (T1/T2, T9/T10 and
F9/F10) and sphenoidal electrodes did not reveal epilep-
tiform abnormalities. For research purpose, sensory
evoked potentials [SEPs: visual (VEP), brainstem audi-
tory (BAEP) and somatosensory (SSEP) evoked poten-
tials)] and transcranial magnetic stimulation (TMS) were
done five times (before start of treatment and at the end
of 15, 30, 60 and 90 days after treatment) to assess the
excitability and function of the motor and sensory cor-
tices. In each test of SEPs, a peripheral sense organ is
electrically stimulated and conduction velocities were
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applied to the motor cortex and motor evoked poten-
tials (MEPs) were recorded from contralateral extremity
muscles [16].
EPs recordings revealed enhanced amplitude of P100
of VEP and delayed N20 (cortical point) of SSEP. TMS
recordings revealed increased size of MEPs and short
CSP (table 1). The cortical silent period (CSP) is
referred to the period of electromyographic suppression
elicited when an individual is instructed to maintain
muscle contraction and a single suprathreshold TMS
pulse is applied to the motor cortex contralateral to the
target muscle. CSP is considered as a post-TMS inhibi-
tory phenomenon that reflects the integrity of GABA-
ergic intracortical inhibitory control [17].
Valproate (1000 mg/day) was prescribed as a prophy-
lactic treatment. VPA is a known antiepileptic drug
which increases brain levels of GABA or enhances
GABA action. Occasionally, eletriptan (Relpax 40 mg
per needed) was prescribed as a treatment for acute
migraine. Triptans constrict blood vessels and possibly
inhibit inflammation of the blood vessels (vascular ele-
ment and not neural). Shortly after the start of treat-
ment, the patient experienced marked clinical and
neurophysiological improvement (tables 1 and 2). The
decision to continue VPA for at least 6-8 months was
discussed with the patient. A gradual and slow decrease
in the dose will be undertaken if the patient judges the
amelioration of clinical manifestations as sufficient.
Tapering of treatment will be undertaken over a period
of 6-8 weeks. If there is a clinical aggravation during
tapering, the previous (or initial) dose will be repeated.
The possibility of life-long treatment with VPA was
discussed with the patient due to unusual manifestations
and complex pattern of inheritance of his illness.
Interestingly, as the patient recognized eating fish or
i t sp r o d u c t sa sat r i g g e rf o ra b d o m i n a lc o l i c ,h ef r e -
quently tried fish to evaluate the therapeutic efficacy of
VPA.
This study was conducted according to the principles
established in Helsinki and approved by Assiut Univer-
sity Hospital ethics committee. Informed written con-
sent was obtained from the patient to publish the details
of his clinical history, laboratory and imaging data.
Discussion
In clinical practice, the presence of family history of
common migraine and a trigger for the attack remain
the key tools to explain why this patient was born with
a liability for migraine. In general, heritability in
migraine is estimated to be 40-60% [18]. Migraine phe-
notypes are genetically complex disorders due to the
presence of different liability loci for migrainous head-
ache or aura, variable genetic load (multiple susceptibil-
ity genes), and various polymorphisms in the related
genes [19]. In families with common migraine, migraine
susceptibility genes (genetic load or gene penetrance)
Table 1 Transcranial magnetic stimulation results (before
and after treatment)
Patient Control
RT LT
MEP Amplitude, mv 0.94 ± 0.4
Before treatment 6.0 4.6
After treatment by:
15 days 0.82 1.4
30 days 0.80 0.89
60 days 0.85 0.80
90 days 0.82 0.86
CSP, ms 94.8 ± 5.9
Before treatment 75 71
After treatment by:
15 days 125 134
30 days 135 132
60 days 132 135
90 days 135 135
MEP: Motor evoked potential, CSP: cortical silent period
Table 2 Evoked potentials results (before and after
treatment)
Patient Control
RT LT
VEP, ms 93.2 ± 3.5
P100, ms
Before treatment 98.5 96.2
After treatment by:
15 days 101.4 103.8
30 days 102.0 100.5
60 days 105.5 99.6
90 days 100.2 101.5
Amplitude, μv 12.5 ± 5.4
Before treatment 32.6 43.2
After treatment by:
15 days 6.5 6.1
30 days 7.1 6.8
60 days 6.8 6.5
90 days 6.2 6.4
SSEP, ms
N20 (cortical) 19.1 ± 0.9
Before treatment 20.5 25.2
After treatment by:
15 days 19.35 24.75
30 days 19.50 18.7
60 days 18.73 19.2
90 days 19.10 18.9
VEP: visual evoked potential; SSEP: somatosensory evoked potential
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threshold which can be modulated by external (e.g. psy-
chosocial stress, preventive therapies ...etc) and/or inter-
nal factors (e.g. hormonal status, anxiety ...etc) [20].
Genetic load not only determines the severity of the
migrainous disorder, but also it determines complica-
tions as chronification by medication overuse [21].
Analyzing the clinical and neurobiological characteris-
tics, the onset of autonomic phenomena, which was man-
ifested as abdominal colic, abdominal flushing, nausea,
pallor, diarrhea, tachycardia and fear or anxiety, simulate
to a great extent auras of temporal lobe epilepsy (TLE).
The amygdale, hypothalamus and medullary cranial
nerve nuclei are possible generators of abdominal colic
and autonomic manifestations, in support: 1) discharges
arising in the amagdala andt r a n s m i t t e dt ot h eg u tv i a
dense direct projections to the dorsal motor nucleus of
the vagus might be responsible for gastrointestinal tract
(GIT) symptoms in TLE, 2) sympathetic pathways from
the amygdala to the GIT can be activated via the
hypothalamus, 3) there are direct sensory pathways from
t h eb o w e lv i at h ev a g u sn e r v et ot h es o l i t a r yn u c l e u so f
the medulla which are heavily connected to the amyg-
dala. These pathways can be activated during intestinal
contractions, and 4) recently, it has been suggested that
orexinegic neurons in the lateral hypothalamus may be a
generator for a migraine attack [22].
Additionally, at adolescence, the patient developed
manifestations of Alice in Wonderland Syndrome which
mainly composed of complex visual illusions. The
described distortions of objects and body images in
absence of a concomitant attack of vertigo are sugges-
tive of involvement of the posterior part of the right
parietal lobe (non-dominant) with and without involve-
ment of the temporal lobe. The occurrence of auditory
illusions (consisted of loudening or muffling of ambient
sounds) suggests involvement of the posterior superior
temporal lobule. While the primary visual hallucinations
associated with migraine suggest involvement of the stri-
ate and extra-striate regions of the occipital lobe [9].
Patients with AIWS know that the distorted experiences
of their bodies or the environment are not real. The
complex perceptual changes in AWLS are mainly visual
but not hallucinatory. In, AWLS, the sensory inputs are
normal but the faulty sensory processing results in an
inappropriate pattern of cortical excitation, while in hal-
lucination, the sensory inputs or hallucinations represent
a release phenomena due to defective sensory input
caused by the faulty stimulation of the associative cor-
tices [12,13].
The presence of atypical manifestations, progressive
weight loss and reduced growth mandate medical diag-
nostic workup for exclusion of an organic cause. Neu-
roimaging and neurophysiologic assessments were
needed to exclude other causes of AWLS as epilepsy [9],
infectious mononucleosis [23], epstein-Barr virus infec-
tion [24], cerebral vasculitis [25], psychosis [26] and
drug adverse effect or intoxication [27,28]. Normal diffu-
sion-weighted MRI is consistent with the diagnosis of
migraine. Changes in cerebral blood flow were identified
during and in-between headaches in migraine with and
without aura. White matter hyperintensities were found
in MRI of patients with migraine [29]. Recently, cerebral
perfusion abnormalities were identified by functional
neuroimaging studies (as SPECT) done during or imme-
diately after attacks of migraine with aura [30].
SEPs and TMS results indicate cortical hyperexcitabil-
ity in multiple brain regions or diffuse brain involve-
ment. Enhanced amplitude of P100 of VEP is indicative
of occipital cortical hyperexcitability. Delayed N20 (cor-
tical point) of SSEP is indicative of parietal lobe dys-
function. Increase in the size of motor responses or
MEPs and short CSP are indicative of motor neuronal
hyperexcitability. In accordance, independent evidences
from VEPs and TMS, recordings and psychophysics
indicate the presence of deficient habituation and
changes in neuronal excitability during and in between
the attacks of migraine [31,32].
The neurophysiologic changes observed in migraine
could offer explanation for the migraine mechanism. In
general, cortical hyperexcitability is due to imbalance
between the cortical inhibitory GABA-ergic (gamma
aminobutyric acid) and excitatory glutaminergic circuits
[33]. VPA increases brain levels of GABA or enhances
GABA action, thus improves the patient’s symptoms.
Under normal conditions, cortical excitability is largely
regulated by GABA-ergic inhibitory interneurons
through GABA receptors (type A and B). GABA recep-
tors occupy ~70-80% of the 2
nd,3
rd and 5
th cortical
layers. Fast and early cortical motor inhibitions are
mediated by GABAA receptors, while slow and late G-
protein-coupled inhibitions are mediated by GABAB
receptors. In fact, neuronal excitability is governed by
the complex interplay of channel currents. Changes in
ion channels as a result of hereditary mutations could
result in minimal or episodic changes in neuronal
micro-environment. These changes might be sufficient
to cause transient neuronal hyperexcitability. It has been
found that the subpopulations of cortical neurons have
different physiological properties in response to different
stimuli, thus might be differentially modulated in
migraine extremes. Furthermore, expression of a single
mutation in different cell types, networks and develop-
mental periods has been suggested to underlie the coex-
istence of common migraine, atypical migraine auras, or
a non-epileptic paroxysmal disorder in one individual or
family [34]. These explanations might concur with the
manifestations observed in our patient.
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We suggest that the occurrence of two different
migraine phenomena in one patient might be the result
of chronicity and the concomitant central sensitization
process [35]. Due to the complex manifestations and
unusual pattern of inheritance, it is important to point
that the treatment option of this patient with VPA may
be life-long.
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